Literature DB >> 12649236

Evidence of Plasmodium falciparum malaria resistant to atovaquone and proguanil hydrochloride: case reports.

Anna Färnert1, Johan Lindberg, Pedro Gil, Göte Swedberg, Yngve Berqvist, Mita M Thapar, Niklas Lindegårdh, Sándor Berezcky, A Björkman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12649236      PMCID： PMC151974          DOI： 10.1136/bmj.326.7390.628

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase.

Authors:  W Sirawaraporn; T Sathitkul; R Sirawaraporn; Y Yuthavong; D V Santi
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

Review 2.  Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group.

Authors:  S Looareesuwan; J D Chulay; C J Canfield; D B Hutchinson
Journal:  Am J Trop Med Hyg       Date:  1999-04       Impact factor: 2.345

3.  Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site.

Authors:  M Korsinczky; N Chen; B Kotecka; A Saul; K Rieckmann; Q Cheng
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

4.  Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria.

Authors:  Quinton L Fivelman; Geoffrey A Butcher; Ipemida S Adagu; David C Warhurst; Geoffrey Pasvol
Journal:  Malar J       Date:  2002-02-08       Impact factor: 2.979

5.  Efficacy and pharmacokinetics of atovaquone and proguanil in children with multidrug-resistant Plasmodium falciparum malaria.

Authors:  A Sabchareon; P Attanath; P Phanuaksook; P Chanthavanich; Y Poonpanich; D Mookmanee; T Chongsuphajaisiddhi; B M Sadler; Z Hussein; C J Canfield; D B Hutchinson
Journal:  Trans R Soc Trop Med Hyg       Date:  1998 Mar-Apr       Impact factor: 2.184
  5 in total
  22 in total

1.  Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum.

Authors:  Quinton L Fivelman; Ipemida S Adagu; David C Warhurst
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

2.  First case of emergence of atovaquone-proguanil resistance in Plasmodium falciparum during treatment in a traveler in Comoros.

Authors:  Helene Savini; Hervé Bogreau; Lionel Bertaux; Housem Bouchiba; Philippe Kraemer; Daniel Parzy; Eric Garnotel; Christophe Rogier; Fabrice Simon; Bruno Pradines
Journal:  Antimicrob Agents Chemother       Date:  2008-04-14       Impact factor: 5.191

3.  [Malaria--current diagnosis and therapy].

Authors:  Isabel Barreto Miranda; Thomas Löscher
Journal:  Med Klin (Munich)       Date:  2009-07-15

4.  Molecular characterization of the cytochrome b gene and in vitro atovaquone susceptibility of Plasmodium falciparum isolates from Kenya.

Authors:  Luicer A Ingasia; Hoseah M Akala; Mabel O Imbuga; Benjamin H Opot; Fredrick L Eyase; Jacob D Johnson; Wallace D Bulimo; Edwin Kamau
Journal:  Antimicrob Agents Chemother       Date:  2015-01-12       Impact factor: 5.191

Review 5.  Antimalarial Drug Resistance: A Threat to Malaria Elimination.

Authors:  Didier Menard; Arjen Dondorp
Journal:  Cold Spring Harb Perspect Med       Date:  2017-07-05       Impact factor: 6.915

6.  Plasmodium chabaudi chabaudi malaria parasites can develop stable resistance to atovaquone with a mutation in the cytochrome b gene.

Authors:  Ana Afonso; Zoraima Neto; Helena Castro; Dinora Lopes; Ana C Alves; Ana M Tomás; Virgílio D Rosário
Journal:  Malar J       Date:  2010-05-21       Impact factor: 2.979

7.  Treatment of murine cerebral malaria by artemisone in combination with conventional antimalarial drugs: antiplasmodial effects and immune responses.

Authors:  W Armand Guiguemde; Nicholas H Hunt; Jintao Guo; Annael Marciano; Richard K Haynes; Julie Clark; R Kiplin Guy; Jacob Golenser
Journal:  Antimicrob Agents Chemother       Date:  2014-06-09       Impact factor: 5.191

8.  Antimalarial 4(1H)-pyridones bind to the Qi site of cytochrome bc1.

Authors:  Michael J Capper; Paul M O'Neill; Nicholas Fisher; Richard W Strange; Darren Moss; Stephen A Ward; Neil G Berry; Alexandre S Lawrenson; S Samar Hasnain; Giancarlo A Biagini; Svetlana V Antonyuk
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-06       Impact factor: 11.205

9.  Early treatment failure during treatment of Plasmodium falciparum malaria with atovaquone-proguanil in the Republic of Ivory Coast.

Authors:  Nathalie Wurtz; Aurélie Pascual; Adeline Marin-Jauffre; Housem Bouchiba; Nicolas Benoit; Marc Desbordes; Maryse Martelloni; Vincent Pommier de Santi; Georges Richa; Nicolas Taudon; Bruno Pradines; Sébastien Briolant
Journal:  Malar J       Date:  2012-05-02       Impact factor: 2.979

10.  In vitro atovaquone/proguanil susceptibility and characterization of the cytochrome b gene of Plasmodium falciparum from different endemic regions of Thailand.

Authors:  Rommanee Khositnithikul; Peerapan Tan-Ariya; Mathirut Mungthin
Journal:  Malar J       Date:  2008-01-28       Impact factor: 2.979
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.